Search results for "Prostate cancer"
PSA screening halves cancer mortality
Cancer diagnoses often given quickly, impersonallyEmail improved care for diabetics
https://immattersacp.org/weekly/archives/2010/07/13/4.htm
13 Jul 2010
Metastatic disease reduced in PSA screening era, study indicates
Prostate-specific antigen (PSA) screening reduced the number of men presenting with metastatic prostate cancer, a new study found.
https://immattersacp.org/weekly/archives/2012/08/07/2.htm
7 Aug 2012
Propoxyphene withdrawn, bevacizumab loses indication
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/02/fda.htm
1 Feb 2011
Simulation model suggests active surveillance offers greatest quality-adjusted life expectancy
Recommended therapies after ischemic stroke less likely to be received by the elderly
https://immattersacp.org/weekly/archives/2010/12/07/5.htm
7 Dec 2010
Warnings on prostate drugs, HIV combination therapy
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/01/fda.htm
1 Jan 2011
Tailor prostate screening based on life expectancy, ASCO recommends
A provisional clinical opinion from the American Society of Clinical Oncology (ASCO) recommends against prostate-specific antigen screening for men with a life expectancy of 10 years or less.
https://immattersacp.org/weekly/archives/2012/07/24/2.htm
24 Jul 2012
Peanut butter recall issued, reminder for topical anesthetics
A summary of approvals, recalls, warnings and alerts.
https://immattersacp.org/archives/2009/03/fda.htm
1 Mar 2009
Research model supports strategies that increase PSA screening interval and age-specific thresholds for biopsy
Using higher thresholds for biopsy referral for older men and screening men with initially low prostate-specific antigen (PSA) levels less frequently seem to reduce harms of screening while preserving lives, a study found.
https://immattersacp.org/weekly/archives/2013/02/05/5.htm
5 Feb 2013
Rethinking the value of the annual exam
Patients expect it and internists won't let it go. But does the evidence support the need for the periodic health exam? Experts weigh in on the value of regularly seeing a patient on a preventive basis.
https://immattersacp.org/archives/2010/01/annual.htm
1 Jan 2010
Clarification to a previous issue
In last week's ACP InternistWeekly, the first sentence of the item on reimbursement cuts and prostate drugs should have read “Medicare reimbursement cuts were associated with reduced use of androgen-deprivation therapy for prostate cancer, particularly among men for whom the benefits of such therapy were unclear.” The item has been updated.
https://immattersacp.org/weekly/archives/2010/11/16/8.htm
16 Nov 2010